Correction: Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model <i>in vivo</i>. [PDF]
Li H, Xi Y, Xin X, Feng Q, Hu Y.
europepmc +1 more source
Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies
AMP‐activated protein kinase (AMPK) is a key evolutionarily conserved sensor of energy homeostasis, which is implicated in metabolic health and disease, as well as in ageing. Here, we show that direct pharmacological activation of AMPK with the compound 991 in vivo extends lifespan in multiple model organisms: the fission yeast Schizosaccharomyces ...
Eliano dos Santos +15 more
wiley +1 more source
Correction: Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model. [PDF]
PLOS One Staff.
europepmc +1 more source
A metaanalysis of 34 studies/37 cohorts using the Siemens Healthineers ELF test for biopsy‐staged F2, F3, or F4 MASLD‐associated fibrosis validates 9.0 (≥F2), 9.8 (≥F3), and 11.3 (F4) cut‐offs, and establishes 10.5 as a high‐specificity F4 cut‐off. This potentially holds implications for guideline revisions and aiding qualification for antifibrotic ...
Matthew F. W. Gee +6 more
wiley +1 more source
Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning. [PDF]
Lin Y, Song J, Li X.
europepmc +1 more source
Background and Purpose Lobeglitazone is a thiazolidinedione and PPARγ agonist that improves metabolic parameters and hepatic steatosis, but its mechanisms are not fully understood. This study investigated the effects of lobeglitazone on hepatic transcriptomic and metabolic profiles in a rat model of obesity and Type 2 diabetes mellitus.
Hyekyung Yang +6 more
wiley +1 more source
Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. [PDF]
Brisnovali NF, Haney C, Goedeke L.
europepmc +1 more source
Proteomic discovery and validation of EGFL7 as a potential non‐invasive biomarker in MASLD. EGFL7 was identified as the top‐ranked proteomic feature in a clinical cohort, demonstrated diagnostic performance comparable to FIB‐4 for fibrosis assessment, and was associated with increased all‐cause mortality risk in the UK Biobank.
Heather Collis +11 more
wiley +1 more source
Butein Alleviates Non-Alcoholic Steatohepatitis in Leptin-Deficient Mice by Modulating the PDE4/cAMP/p-CREB Pathway. [PDF]
Guo C +9 more
europepmc +1 more source
Ethanol extract of Polygonatum cyrtonema Hua mitigates non-alcoholic steatohepatitis in mice. [PDF]
Chen D +8 more
europepmc +1 more source

